Twist Bioscience Corporation Common Stock TWST

$118.41 +5.72% at last close
Market Cap$7.64 billion
P/E Ratio—
Div Yield—
Volume1.21M
52-Week Range $23.30$219.71

Analyst Ratings

Consensus
Moderate Buy — 7 Buy · 3 Hold · 1 Sell (11 analysts)
Avg. Price Target
$135.91 (+14.8% upside)

Full TWST forecast & analyst actions →

Key Stats

Today's Range
$109.97 – $119.81
50-Day Range
$93.68 – $219.71
52-Week Range
$23.30 – $219.71
Volume
1.21 million shs
Average Volume
2.50 million shs
Market Cap
$7.64 billion
P/E Ratio
—
Dividend Yield
—

Short Interest

Short Interest
0.08%
Days to Cover
1.00

About Twist Bioscience Corporation Common Stock

Twist Bioscience Corp provides customizable solutions across the biological continuum, helping customers read, write and innovate in biology. The core of its business is a proprietary platform that allows it to manufacture synthetic DNA by writing DNA on a silicon chip. The company operates as one reportable and operating segment, through which it develops, manufactures and sells DNA Synthesis and Protein Solutions and NGS Applications products and services. It has presence in Americas, EMEA, and APAC. Majority of revenue comes from Americas. Its products are Genes, Oligo Pools, NGS, Variant Libraries, Synthetic Controls, Antibody Discovery, and VDR Solutions.

Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
979
Exchange
XNAS
Listed
2018-10-31

Related Stocks

Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.